title: [Positioning of PROactive and its clinical application in Japan--a new direction in diabetes care discussed by diabetology and circulatory disease specialists: discussion].
authors.forename: Ryuzo
authors.initials: R
authors.lastname: Kawamori
authors.forename: Takashi
authors.initials: T
authors.lastname: Kadowaki
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Daida
authors.forename: Nobuakira
authors.initials: N
authors.lastname: Takeda
authors.forename: John
authors.initials: J
authors.lastname: Dormandy
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003920:Diabetes Mellitus / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000077205:Pioglitazone; D045162:Thiazolidinediones / Q000627:therapeutic use*
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone